-

Shareholder Alert: Robbins LLP Announces It Is Investigating ServiceMaster Global Holdings, Inc. (SERV) for Misleading Shareholders

SAN DIEGO & MEMPHIS, Tenn.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that it is investigating ServiceMaster Global Holdings, Inc. (NYSE: SERV) for alleged violations of the Securities Exchange Act of 1934 and whether the Company's officers and directors breached their fiduciary duties to shareholders. ServiceMaster provides residential and commercial termite and pest control, restoration, and cleaning services. Terminix is ServiceMaster's largest and most profitable business segment.

If you suffered a loss as a result of ServiceMaster's misconduct, click here.

ServiceMaster Global Holdings, Inc. (SERV) Accused of Misleading Shareholders

On October 22, 2019, ServiceMaster announced disappointing preliminary financial results for the third quarter 2019, having missed revenue and earnings estimates. The Company also reported net income of $25 million versus $71 million during the third quarter of the prior year and gave adjusted EBITDA guidance of $415 to $425 million, down from $435 to $445 million. ServiceMaster attributed the disappointing results to "termite damage claims arising primarily from Formosan termite activity" and admitted that this had been a "known issue" since early 2018. Then in November 2019, ServiceMaster disclosed that increased claims would continue to impact the Company through 2020 and that in addition to the "$2 million increase damage claims expense," ServiceMaster "expect[ed] a year-over-year increase from damage claims of approximately $4 million in the fourth quarter." On this news, ServiceMaster's stock price fell almost 12% to close at $35.74 per share.

Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Want to be notified if a class action against ServiceMaster settles? Want to receive free alerts about companies engaged in wrongdoing? Sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:SERV

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Simulation Plus, Inc. (NASDAQ: SLP) Investors Should Contact Robbins LLP for Information About Investigation

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP announces that it is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain officers and directors violated securities laws or breached fiduciary duties owed to shareholdersThe investigation concerns whether Simulation Plus made materially false or misleading statements or omitted material information regarding its financial reporting, internal controls, and business outlook.Investors who purchased Simulation Plus securities and suf...

Acadia Healthcare (NASDAQ: ACHC) Investors: Court Denies Motion to Dismiss Paving Way for Litigation to Proceed; Contact Robbins LLP for Information About Your Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to proceed.The case is continuing after the Court denied defendants’ motion to dismiss the amended complaint. The ruling means the case can proceed past the motion-to-dismiss stage. It does not determine whether the allegations are true or establish liability. Investors who purchased or otherwise acquired Acadia Healt...

Insulet Corporation (NASDAQ: PODD) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026, inclusive (the "Class Period"). The lawsuit alleges that Insulet made materially false or misleading statements regarding its manufacturing controls and the safety and reliability of its insulin delivery products. Investors who su...
Back to Newsroom